19.11.2020 • NewsEvonik

Evonik on Track with PA 12 Expansion

German specialty chemicals producer Evonik says it is on track to complete the ongoing €400 million expansion of its PA 12 portfolio as planned, despite a few logistical challenges related to the coronavirus pandemic.

The first stage of the 50% capacity increase was completed in October, and the plant is now in the commissioning process, the Essen-based company said. Additional units are scheduled to follow in the first quarter of next year, with full completion expected in the first half year.

With output capability of around of 400,000 t/y, Evonik is regarded as the world’s largest producer of the high-performance polyamide used in specialty applications in automotive engineering, gas piping, sports and 3D printing.

“With the new plant complex, we are consolidating our position as a market leader for this high-performance polymer,” said Claus Rettig, who heads Evonik’s Smart Materials division. “PA 12 is part of our growth strategy.”

The company has successfully dealt with minor pandemic-related problems such as interrupted supply chains or entry restrictions for assembly personnel, but no major delays are expected going forward, said Marcus von Twistern, who is overseeing the complete construction project.

Author: Dede Williams, Freelance Journalist

Evonik is on track with the €400 million, 50% expansion of its PA 12...
Evonik is on track with the €400 million, 50% expansion of its PA 12 portfolio, despite minor pandemic-related challenges. The first stage is in the commissioning process, the German company said. Additional units will follow in Q1 2021, with full completion in the first half. (c) Evonik

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.